Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
10x Genomics, Inc.

10x Genomics, Inc. (TXG) Stock Overview

Explore 10x Genomics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

TXG●NASDAQ
HealthcareBiotechnology
$65.05
$5.77(9.73%)
U.S. Market opens in 15h 51m

10x Genomics, Inc. (TXG)

Meyka AI Score

Z

Key Financials

Market Cap7.8B
P/E Ratio-110.92
EPS (TTM)$-0.59
ROE-0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$82.77
3 Months$113.25
1 Year Target$51.10

TXG Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of 10x Genomics, Inc. (NASDAQ: TXG) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, 10x Genomics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of TXG on the NASDAQ shows an RSI of 44.55, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $51.10 for the NASDAQ listing.

Key metrics behind 10x Genomics, Inc.'s NASDAQ-traded stock include a P/E ratio of -110.92 and a market capitalization of 7.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of TXG on the NASDAQ.

Price Performance (NASDAQ: TXG)

1-Day Change
9.73%
5-Day Change
-4.69%
1-Month Change
-19.34%
3-Month Change
25.02%
6-Month Change
201.16%
Year-to-Date (YTD) Change
298.84%
1-Year Change
280.85%
3-Year Change
78.32%
5-Year Change
-61.32%
All-Time (Max) Change
23.32%

Contact Information

https://www.10xgenomics.com
925 401 7300
6230 Stoneridge Mall Road, Pleasanton, CA, 94588-3260

Company Facts

11,780 Employees
IPO DateSep 12, 2019
CountryUS
Actively Trading

Frequently Asked Questions